English

UNAM scientists develop tuberculosis antibiotic from scorpion venom

Tuberculosis is one of the most lethal diseases in the world

The substances also slow down the growth of carcinogenic cells - Photo: File photo/EL UNIVERSAL
18/02/2020 |18:14Newsroom |
Redacción El Universal
Pendiente este autorVer perfil

Experts of the of the National Autonomous University of Mexico discovered that two compounds derived from scorpion venom can fight infections caused by tuberculosis , one of the most lethal diseases in the world.

Through research, scientists proved that the substances also slow down the growth of carcinogenic cells . The compositions were isolated, produced, and patented, according to the UNAM in a statement.

Although tuberculosis , a bacterial infection, can be prevented a cured , doctor Lourival Domingos Possani Postay from IBT said that “every day, nearly 45,000 people die and 30,000 get infected” while the (CENAPRECE) reported 2,569 deaths for this disease in Mexico in 2016 .

Newsletter
Recibe en tu correo las noticias más destacadas para viajar, trabajar y vivir en EU

Recommended:

This discovery could contribute to the problem caused by the treatment against this disease which, due to its six-months duration , is deserted by patients. This causes more resistant strains that need a higher dose of antibiotics and a treatment that could extend to up to four years.

Both components can halt the development of anomalies in malignant cells since they work like the ideal antibiotics to fight tuberculosis and a variety of bacterias .

The first component discovered is red and is called “ 3-5dimethoxy-2(methylthio)cyclohexa-2,5-diene-1,4dione .” It is efficient against Staphylococcus Aureus , a bacteria that causes skin infections and pneumonia.

Recommended:

The second component is blue and is called “5-methoxy-2,3- bis (methylthio) cyclohexa-2,5-diene-1,4-dione .” It attacks the mycobacterium that causes tuberculosis.

“Laboratory work, with biological models , is already done and works. Now we need clinical trials in humans and a pharmaceutical company that is interested can make this product available to people,” stressed doctor Possani, who is part of a group of researchers who have studied the structure of scorpion venoms in Mexico and other countries for over four decades, developing avant - garde cures .

Recommended:

mp